Search results
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 6 days agoAttorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Compass Minerals International ...
Biden’s legacy long game: Rain regulations — now
Politico via Yahoo News· 1 day agoThe Labor Department is expanding overtime pay guarantees to an estimated four million workers and imposing strict fiduciary obligations on sellers of retirement investments ...
AvidXchange and RCI Hospitality have been highlighted as Zacks Bull and Bear of the Day
Zacks via Yahoo Finance· 2 days agoThe hiked distribution will be paid on May 20 to unitholders of record as of the close of business...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 6 days agoThe Data Monitoring Committee recommended to continue the clinical trial without modification of the current protocol, based on the pre-planned review of safety< ...
How to protect yourself against credit card fraud — and where you're most at risk
Yahoo Personal Finance· 6 days agoAs well as reporting suspected scammers to the ... Disclosure: The information in this article has...
5 ways to secure your retirement before Social Security is projected to start cutting benefits in...
Business Insider· 6 days agoSocial Security benefits are projected to be cut by 2035. Learn how to grow your nest egg by saving...
Illinois School Districts Sent Kids to a For-Profit Out-of-State Facility That Isn’t Vetted or...
ProPublica· 5 days agoProPublica is a nonprofit newsroom that investigates abuses of power. Two years ago, Illinois...
Avenir Wellness Solutions Reports Fourth Quarter 2023 Results
Morningstar· 5 days agoSHERMAN OAKS, CA / ACCESSWIRE / May 17, 2024 / Avenir Wellness Solutions, Inc. (OTCQB:AVRW) ("Avenir" or the "Company"), a proprietary broad platform technology and wellness company, today announced ...
Earnings call: Aptose Biosciences targets AML treatment with tuspetinib By Investing.com
Investing.com· 7 days agoAptose Biosciences (NASDAQ:APTO) has focused its efforts on developing tuspetinib as part of a novel...